BioTech Biome Technologies has announced its plans to stop its shares from trading on AIM and re-register as a private limited company. Through its Biome Bioplastics division, the company’s mission is to produce bioplastics that challenge the dominance of oil-based polymers, and ultimately replace them completely. Building on 20 years of development activity, Biome Bioplastics … Continue reading BioTech bids to become latest firm to delist in London